Emily Sun

Emily joined Novo Holdings in 2024 as an Associate in the Principal Investments group. She participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments.

Prior to joining Novo Holdings, Emily was an Investment Banking Analyst on the healthcare team at Morgan Stanley.

Emily holds a BA in Molecular and Cell Biology and a BS in Business Administration from UC Berkeley.